SCHEMBL14667993

SCHEMBL14667993

Cc1ccc(CCCn2c3nc(=O)[nH]c(=O)c-3nc3cc(C)ccc32)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 6/20 0.48
▸ KMT2A Q03164 6/20 0.48
▸ USP2 O75604 4/20 0.48
▸ MAPT P10636 3/20 0.48
▸ KDM4E B2RXH2 3/20 0.48
▸ HTT P42858 3/20 0.48
▸ TDP1 Q9NUW8 2/20 0.48
▸ RXFP1 Q9HBX9 2/20 0.48
▸ IDO1 P14902 1/20 0.48
▸ HAT1 O14929 4/20 0.43
▸ RBBP7 Q16576 4/20 0.43
▸ KAT7 O95251 1/20 0.43
▸ EP300 Q09472 1/20 0.43
▸ CREBBP Q92793 1/20 0.43
▸ RECQL P46063 3/20 0.42
▸ TDP2 O95551 3/20 0.42
▸ NGF P01138 1/20 0.42
▸ NTRK1 P04629 1/20 0.42
▸ BLM P54132 1/20 0.42
▸ CASP7 P55210 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12286942 0.94 KMT2A (0.45) MEN1KMT2AUSP2MAPTKDM4E
SCHEMBL12287116 0.94 KMT2A (0.45) MEN1KMT2AUSP2MAPTKDM4E
SCHEMBL12287013 0.94 MEN1 (0.47) MEN1KMT2AUSP2MAPTKDM4E
SCHEMBL14668016 0.93 MEN1 (0.46) MEN1KMT2AUSP2MAPTKDM4E
SCHEMBL12287042 0.92 MEN1 (0.45) MEN1KMT2AUSP2MAPTKDM4E
SCHEMBL14667994 0.91 MEN1 (0.48) MEN1KMT2AUSP2MAPTKDM4E
SCHEMBL14667981 0.91 MEN1 (0.45) MEN1KMT2AUSP2MAPTKDM4E
SCHEMBL14667966 0.91 MEN1 (0.47) MEN1KMT2AUSP2MAPTKDM4E
SCHEMBL12287067 0.90 MEN1 (0.46) MEN1KMT2AUSP2MAPTKDM4E
SCHEMBL12287007 0.90 KMT2A (0.61) MEN1KMT2AUSP2MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130029980-A1 FLAVIN DERIVATIVES COISH PHILIP D G (US) 2013-01-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130029980-A1 FLAVIN DERIVATIVES BLVRB, FLAD1, FDPS MEN1 4701/4885KMT2A 3363/4885USP2 3968/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback